2.Development of ceftazidime resistance in Burkhoderia pseudomallei in a patient experiencing melioidosis with mediastinal lymphadenitis.
Chia Te KUNG ; Chen Hsiang LEE ; Chao Jui LI ; Hung I LU ; Sheung Fat KO ; Jien Wei LIU
Annals of the Academy of Medicine, Singapore 2010;39(12):945-943
Anti-Bacterial Agents
;
pharmacology
;
therapeutic use
;
Burkholderia pseudomallei
;
drug effects
;
isolation & purification
;
Ceftazidime
;
pharmacology
;
therapeutic use
;
Comorbidity
;
Drug Resistance, Bacterial
;
Humans
;
Lymphadenitis
;
physiopathology
;
Male
;
Mediastinal Diseases
;
physiopathology
;
Melioidosis
;
etiology
;
physiopathology
;
Middle Aged
3.An unusual collision tumour masquerading as a basal cell carcinoma on the nose.
Hwee Chyen LEE ; Ki Wei TAN ; Min Wee CHIA ; Chee Seng SIM
Singapore medical journal 2012;53(12):e267-8
When two or more cutaneous tumours coexist in a single lesion, it is known as a cutaneous collision or contiguous tumour. Various combinations of collisions have been described. Collision tumours often have misleading clinical and histological presentations, and can be a diagnostic challenge. Chondroid syringomas are mixed cutaneous tumours of dual origin, and like collision tumours, are often confused with the more commonly seen cutaneous lesions. As chondroid syringomas are rare, their involvement in collision tumours is an even more peculiar occurrence. We report an unusual case of a cutaneous collision tumour on the nose involving an intradermal naevus and chondroid syringoma. To the best of our knowledge, this is the first time such a combination is reported.
Aged
;
Carcinoma, Basal Cell
;
diagnosis
;
Diagnosis, Differential
;
Female
;
Humans
;
Keratosis, Seborrheic
;
pathology
;
Neoplasms, Multiple Primary
;
pathology
;
Nevus, Pigmented
;
pathology
;
Nose Neoplasms
;
diagnosis
;
Skin Neoplasms
;
pathology
4.New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave
Chih-Chieh LIN ; Yun-Ching HUANG ; Wei-Chia LEE ; Yao-Chi CHUANG
International Neurourology Journal 2020;24(3):211-221
Interstitial cystitis/bladder pain syndrome (IC/BPS), which is characterized by bladder pain and irritative voiding symptoms, is a frustrating disease without effective treatment. The cause is still largely not understood, although urothelium ischemia/hypoxia, apoptosis, denudation, and infiltration of inflammatory cells are common histopathological findings. The current uncertainty regarding the etiology and pathology of IC/BPS has a negative impact on its timely and successful treatment; therefore, the development of new treatment modalities is urgently needed. Herein, we present advances in our knowledge on this topic and review the potential application of regenerative medicine for the treatment of IC/BPS. This article provides information on the basic characteristics and clinical evidence of stem cells, platelet-rich plasma (PRP), and low-energy shock waves (LESWs) based on a literature review with a search strategy for articles related to IC/BPS, stem cells, PRP, and LESW published in MEDLINE and PubMed. Stem cells, PRP, and LESW, which modulate inflammatory processes and promote tissue repair, have been proven to improve bladder regeneration, relieve bladder pain, inhibit bladder inflammation, and increase bladder capacity in some preclinical studies. However, clinical studies are still in their infancy. Based on the mechanisms of action of stem cells, PRP, and LESW documented in many preclinical studies, the potential applications of regenerative medicine for the treatment of IC/BPS is an emerging frontier of interest. However, solid evidence from clinical studies remains to be obtained.
5.Refined protocol for newly onset identification in non-obese diabetic mice: an animal-friendly, cost-effective, and efficient alternative
Chia-Chi LIAO ; Chia-Chun HSIEH ; Wei-Chung SHIA ; Min-Yuan CHOU ; Chuan-Chuan HUANG ; Jhih-Hong LIN ; Shu-Hsien LEE ; Hsiang-Hsuan SUNG
Laboratory Animal Research 2024;40(2):269-279
Background:
Therapeutic interventions for diabetes are most effective when administered in the newly onset phase, yet determining the exact onset moment can be elusive in practice. Spontaneous autoimmune diabetes among NOD mice appears randomly between 12 and 32 weeks of age with an incidence range from 60 to 90%. Furthermore, the disease often progresses rapidly to severe diabetes within days, resulting in a very short window of newly onset phase, that poses significant challenge in early diagnosis. Conventionally, extensive blood glucose (BG) testing is typically required on large cohorts throughout several months to conduct prospective survey. We incorporated ultrasensitive urine glucose (UG) testing into an ordinary BG survey process, initially aiming to elucidate the lag period required for excessive glucose leaking from blood to urine during diabetes progression in the mouse model.
Results:
The observations unexpectedly revealed that small amounts of glucose detected in the urine often coincide with, sometimes even a couple days prior than elevated BG is diagnosed. Accordingly, we conducted the UG-based survey protocol in another cohort that was validated to accurately identified every individual near onset, who could then be confirmed by following few BG tests to fulfill the consecutive BG + criteria. This approach required fewer than 95 BG tests, compared to over 700 tests with traditional BG survey, to diagnose all the 37–38 diabetic mice out of total 60. The average BG level at diagnosis was slightly below 350 mg/dl, lower than the approximately 400 mg/dl observed with conventional BG monitoring.
Conclusions
We demonstrated a near perfect correlation between BG + and ultrasensitive UG + results in prospective survey with no lag period detected under twice weekly of testing frequency. This led to the refined protocol based on surveying with noninvasive UG testing, allowing for the early identification of newly onset diabetic mice with only a few BG tests required per mouse. This protocol significantly reduces the need for extensive blood sampling, lancet usage, labor, and animal distress, aligning with the 3Rs principle. It presents a convenient, accurate, and animal-friendly alternative for early diabetes diagnosis, facilitating research on diagnosis, pathogenesis, prevention, and treatment.
6.IgE-Binding Epitope Mapping and Tissue Localization of the Major American Cockroach Allergen Per a 2.
Mey Fann LEE ; Chia Wei CHANG ; Pei Pong SONG ; Guang Yuh HWANG ; Shyh Jye LIN ; Yi Hsing CHEN
Allergy, Asthma & Immunology Research 2015;7(4):376-383
PURPOSE: Cockroaches are the second leading allergen in Taiwan. Sensitization to Per a 2, the major American cockroach allergen, correlates with clinical severity among patients with airway allergy, but there is limited information on IgE epitopes and tissue localization of Per a 2. This study aimed to identify Per a 2 linear IgE-binding epitopes and its distribution in the body of a cockroach. METHODS: The cDNA of Per a 2 was used as a template and combined with oligonucleotide primers specific to the target areas with appropriate restriction enzyme sites. Eleven overlapping fragments of Per a 2 covering the whole allergen molecule, except 20 residues of signal peptide, were generated by PCR. Mature Per a 2 and overlapping deletion mutants were affinity-purified and assayed for IgE reactivity by immunoblotting. Three synthetic peptides comprising the B cell epitopes were evaluated by direct binding ELISA. Rabbit anti-Per a 2 antibody was used for immunohistochemistry. RESULTS: Human linear IgE-binding epitopes of Per a 2 were located at the amino acid sequences 57-86, 200-211, and 299-309. There was positive IgE binding to 10 tested Per a 2-allergic sera in 3 synthetic peptides, but none in the controls. Immunostaining revealed that Per a 2 was localized partly in the mouth and midgut of the cockroach, with the most intense staining observed in the hindgut, suggesting that the Per a 2 allergen might be excreted through the feces. CONCLUSIONS: Information on the IgE-binding epitope of Per a 2 may be used for designing more specific diagnostic and therapeutic approaches to cockroach allergy.
Amino Acid Sequence
;
Cockroaches
;
DNA Primers
;
DNA, Complementary
;
Enzyme-Linked Immunosorbent Assay
;
Epitope Mapping*
;
Epitopes
;
Epitopes, B-Lymphocyte
;
Feces
;
Humans
;
Hypersensitivity
;
Immunoblotting
;
Immunoglobulin E
;
Immunohistochemistry
;
Mouth
;
Peptides
;
Periplaneta*
;
Polymerase Chain Reaction
;
Protein Sorting Signals
;
Taiwan
7.Prevalence of thyroid malignancy and hormonal dysfunction following radiation exposure in childhood.
Yee Sian TIONG ; Edwin Tong Yuen HAO ; Chia Ching LEE ; Rajeev PARAMESWARAN ; Timothy CHEO ; Wei Li Cindy HO ; Samantha Peiling YANG
Annals of the Academy of Medicine, Singapore 2021;50(5):402-410
INTRODUCTION:
Childhood radiation exposure is a known risk factor for thyroid malignancy and dysfunction. However, local data are limited and there is no consensus on the modality and frequency of screening in this high-risk group.
METHODS:
Retrospective analysis study evaluating patients with childhood radiation exposure in 2006-2016 and minimum of 1-year follow-up.
RESULTS:
Of the 132 childhood cancer survivors in the study, thyroid malignancy was detected in 2 cases (1.5%) and thyroid nodules in 13 (9.8%). The earliest thyroid malignancy was detected 5 years post-radiotherapy via ultrasound. Of the 84 patients who had screening thyroid function test, 26 (31.0%) were detected with abnormal test results post-radiation, majority being subclinical hypothyroidism.
CONCLUSION
Regular screening via clinical examination for thyroid nodules should be performed at least annually. Where feasible and if resources permit, consideration should be given to using ultrasound for thyroid nodule(s) and malignancy screening at 5 years post-radiation therapy. Screening for thyroid dysfunction can be considered from 6-12 months post-radiotherapy.
8.Development and feasibility of a mobile-based vestibular rehabilitation therapy application for healthy older adults.
Lee Huan TEE ; Wei Wei SEAH ; Christina Hui Ling CHIA ; Eng Chuan NEOH ; Peter LIM ; Sze Wong LIAW ; Peng Shorn SIEW ; Eu Chin HO
Annals of the Academy of Medicine, Singapore 2022;51(8):514-516
9.The Clinical Characteristics and Manifestation of Anxious Depression Among Patients With Major Depressive Disorders-Results From a Taiwan Multicenter Study
Huang-Li LIN ; Wei-Yang LEE ; Chun-Hao LIU ; Wei-Yu CHIANG ; Ya-Ting HSU ; Chin-Fu HSIAO ; Hsiao-Hui TSOU ; Chia-Yih LIU
Psychiatry Investigation 2024;21(6):561-572
Objective:
Anxious depression is a prevalent characteristic observed in Asian psychiatric patients diagnosed with major depressive disorder (MDD). This study aims to investigate the prevalence and clinical presentation of anxious depression in Taiwanese individuals diagnosed with MDD.
Methods:
We recruited psychiatric outpatients aged over 18 who had been diagnosed with MDD through clinical interviews. This recruitment took place at five hospitals located in northern Taiwan. We gathered baseline clinical and demographic information from the participants. Anxious depression was identified using a threshold of an anxiety/somatization factor score ≥7 on the 21-item Hamilton Rating Scale for Depression (HAM-D).
Results:
In our study of 399 patients (84.21% female), 64.16% met the criteria for anxious depression. They tended to be older, married, less educated, with more children, and an older age of onset. Anxious depression patients had higher HAM-D and Clinical Global Impression–Severity scale score, more panic disorder (without agoraphobia), and exhibited symptoms like agitation, irritability, concentration difficulties, psychological and somatic anxiety, somatic complaints, hypochondriasis, weight loss, and increased insight. Surprisingly, their suicide rates did not significantly differ from non-anxious depression patients. This highlights the importance of recognizing and addressing these unique characteristics.
Conclusion
Our study findings unveiled that the prevalence of anxious depression among Taiwanese outpatients diagnosed with MDD was lower compared to inpatients but substantially higher than the reported rates in European countries and the United States. Furthermore, patients with anxious depression exhibited a greater occurrence of somatic symptoms.
10.Health Care Utilization and Expenditures of Patients with Diabetes Comorbid with Depression Disorder: A National Population-Based Cohort Study.
Chun Jen HUANG ; Hui Min HSIEH ; Herng Chia CHIU ; Peng Wei WANG ; Mei Hsuan LEE ; Chih Yi LI ; Ching Hua LIN
Psychiatry Investigation 2017;14(6):770-778
OBJECTIVE: The study investigated to compare health care utilization and expenditures between diabetic patients with and without depression in Taiwan. METHODS: Health care utilization and expenditure among diabetic patients with and without depression disorder during 2000 and 2004 were examined using Taiwan's population-based National Health Insurance claims database. Health care utilization included outpatient visits and the use of inpatient services, and health expenditures were outpatient, inpatient, and total medical expenditures. Moreover, general estimation equation models were used for analyzing the factors associated with outpatient visits and expenditures. Multiple logistic regression analysis was applied for identifying the factors associated with hospitalization. RESULTS: The average annual outpatient visits and annual total medical expenditures in the study period were 44.23–52.20; NT$87,496–133,077 and 30.75–32.92; NT$64,411–80,955 for diabetic patients with and without depression. After adjustment for covariates, our results revealed that gender and complication were associated with out-patient visits. Moreover, the time factor was associated with the total medical expenditure, and residential urbanization and complication factors were associated with hospitalization. CONCLUSION: Health care utilization and expenditures for diabetic patients with depression were significantly higher than those without depression. Sex, complications, time, and urbanization are the factors associated with health care utilization and expenditures.
Cohort Studies*
;
Delivery of Health Care*
;
Depression*
;
Health Expenditures*
;
Hospitalization
;
Humans
;
Inpatients
;
Logistic Models
;
National Health Programs
;
Outpatients
;
Patient Acceptance of Health Care*
;
Taiwan
;
Time Factors
;
Urbanization